Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

6 of 6 completed trials have results

Key Signals

6 with results

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT03859401Not ApplicableCompleted

Exercise-Induced Hypoglycemia Prevention in Adults With Type 1 Diabetes Using an Artificial Pancreas

Role: lead

NCT06017089Not ApplicableCompleted

The Pediatric Artificial Pancreas Automated Initialization Trial

Role: lead

NCT05528770Not ApplicableCompleted

Evaluation of The Postprandial Impact of Automated Priming Bolus for Full Closed Loop Insulin Delivery

Role: lead

NCT06633965Not ApplicableCompleted

Safety and Feasibility Testing of a Smaller Network Version of AIDANET

Role: lead

NCT01945060Not ApplicableCompleted

Closed Loop Control in Adolescents Using Heart Rate as Exercise Indicator

Role: lead

NCT04796779Not ApplicableCompleted

The Pediatric Artificial Pancreas (PEDAP) Trial of Control-IQ Technology in Young Children in Type 1 Diabetes

Role: lead

All 6 trials loaded